Neurocognitive Functions of Recovered COVID-19 Patients
NCT ID: NCT04622748
Last Updated: 2020-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
160 participants
OBSERVATIONAL
2020-07-10
2020-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19
Recovered COVID-19 patients in Wuhan
Trier Social Stress Test
8-min oral calculation and 5-min speech
Healthy Control
Uninfected people in Wuhan
Trier Social Stress Test
8-min oral calculation and 5-min speech
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trier Social Stress Test
8-min oral calculation and 5-min speech
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to participate in this study and sign informed consent.
Exclusion Criteria
* Subjects who are in menstruation and pregnancy;
* Subjects suffering from cardiopulmonary diseases before the new coronary pneumonia epidemic (such as heart disease, pulmonary hypertension, congestive heart failure, etc.);
* Subjects with severe disturbances in consciousness, cognitive dysfunction, mental disorders, visual and hearing disorders, bone and joint diseases, etc.;
* Subjects with abnormal immune system and severe organ dysfunction (heart, liver, kidney, etc.);
* Subjects who are unwilling to participate in this study and cannot complete all surveys and cognitive function tests.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Sixth Hospital
OTHER
Wuhan Wuchang Hospital
UNKNOWN
National Institute on Drug Dependence, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lin Lu, Dr.
Role: STUDY_DIRECTOR
National Institute on Drug Dependence, Peking University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wuhan Wuchang Hospital
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Guofu Huang, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDD-2020-Neurocognition
Identifier Type: -
Identifier Source: org_study_id